A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC) (Q82808934)
scientific article published on 13 March 2006
Language:
(P31) (Q13442814)
(P304) 1007-1013
(P433) 6
(P478) 17
(P577) Monday, March 13, 2006
(P921) (Q47912)
(Q423762)
(P1433) (Q326122)
(P1476) "A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC)" (language: en)
(P2093) C Kollmannsberger
M Schittenhelm
F Honecker
J Tillner
D Weber
K Oechsle
L Kanz
C Bokemeyer
other details
description scientific article published on 13 March 2006

External Links